Patrick J - Search Results

1

The plasma concentration and LDL-C relationship in patients receiving ezetimibe.

Ezzet F, Wexler D, Statkevich P, Kosoglou T, Patrick J, Lipka L, Mellars L, Veltri E, Batra V. Ezzet F, et al. Among authors: patrick j. J Clin Pharmacol. 2001 Sep;41(9):943-9. doi: 10.1177/00912700122010915. J Clin Pharmacol. 2001. PMID: 11549098 Clinical Trial.

2

Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin.

Kosoglou T, Meyer I, Veltri EP, Statkevich P, Yang B, Zhu Y, Mellars L, Maxwell SE, Patrick JE, Cutler DL, Batra VK, Affrime MB. Kosoglou T, et al. Br J Clin Pharmacol. 2002 Sep;54(3):309-19. doi: 10.1046/j.1365-2125.2002.01633.x. Br J Clin Pharmacol. 2002. PMID: 12236852 Free PMC article. Clinical Trial.

3

Disposition of the selective cholesterol absorption inhibitor ezetimibe in healthy male subjects.

Patrick JE, Kosoglou T, Stauber KL, Alton KB, Maxwell SE, Zhu Y, Statkevich P, Iannucci R, Chowdhury S, Affrime M, Cayen MN. Patrick JE, et al. Drug Metab Dispos. 2002 Apr;30(4):430-7. doi: 10.1124/dmd.30.4.430. Drug Metab Dispos. 2002. PMID: 11901097 Clinical Trial.

4

Effect of food on the oral bioavailability of isosorbide-5-mononitrate administered as an extended-release tablet.

Kosoglou T, Kazierad DJ, Schentag JJ, Patrick JE, Heimark L, Radwanski E, Christopher D, Flannery BE, Affrime MB. Kosoglou T, et al. Among authors: patrick je. J Clin Pharmacol. 1995 Feb;35(2):151-8. doi: 10.1002/j.1552-4604.1995.tb05004.x. J Clin Pharmacol. 1995. PMID: 7751425

5

Pharmacokinetics of isosorbide-5-mononitrate after oral administration of an extended-release mononitrate formulation versus a standard dinitrate formulation.

Kosoglou T, Patrick JE, Cohen A, Radwanski E, Christopher D, Affrime MB. Kosoglou T, et al. Among authors: patrick je. Clin Ther. 1995 Mar-Apr;17(2):241-51. doi: 10.1016/0149-2918(95)80022-0. Clin Ther. 1995. PMID: 7614524 Clinical Trial.

6

Disposition of 14C-eptifibatide after intravenous administration to healthy men.

Alton KB, Kosoglou T, Baker S, Affrime MB, Cayen MN, Patrick JE. Alton KB, et al. Among authors: patrick je. Clin Ther. 1998 Mar-Apr;20(2):307-23. doi: 10.1016/s0149-2918(98)80094-5. Clin Ther. 1998. PMID: 9589822 Clinical Trial.

7

Disposition and pharmacokinetics of temozolomide in rat.

Reyderman L, Statkevich P, Thonoor CM, Patrick J, Batra VK, Wirth M. Reyderman L, et al. Among authors: patrick j. Xenobiotica. 2004 May;34(5):487-500. doi: 10.1080/00498250410001685737. Xenobiotica. 2004. PMID: 15370964

8

Disposition of loratadine in healthy volunteers.

Ramanathan R, Reyderman L, Kulmatycki K, Su AD, Alvarez N, Chowdhury SK, Alton KB, Wirth MA, Clement RP, Statkevich P, Patrick JE. Ramanathan R, et al. Among authors: patrick je. Xenobiotica. 2007 Jul;37(7):753-69. doi: 10.1080/00498250701463317. Xenobiotica. 2007. PMID: 17620221

9

Disposition of desloratadine in healthy volunteers.

Ramanathan R, Reyderman L, Su AD, Alvarez N, Chowdhury SK, Alton KB, Wirth MA, Clement RP, Statkevich P, Patrick JE. Ramanathan R, et al. Among authors: patrick je. Xenobiotica. 2007 Jul;37(7):770-87. doi: 10.1080/00498250701463325. Xenobiotica. 2007. PMID: 17620222

10

Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of ezetimibe (Zetia).

Ghosal A, Hapangama N, Yuan Y, Achanfuo-Yeboah J, Iannucci R, Chowdhury S, Alton K, Patrick JE, Zbaida S. Ghosal A, et al. Among authors: patrick je. Drug Metab Dispos. 2004 Mar;32(3):314-20. doi: 10.1124/dmd.32.3.314. Drug Metab Dispos. 2004. PMID: 14977865

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,229 results

Search Page

Filters